Introduction Executive Summary Rabies infection: Overview • Causes • Mechanism of Action • Signs and Symptoms • Diagnosis • Disease Management Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment • Assessment by Product Type • Assessment by Stage and Product Type • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type Late Stage Products (Phase III) • Comparative Analysis SYN-023: Synermore Biologics • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II) • Comparative Analysis PIKA Rabies vaccine - Yisheng Biopharma • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Preclinical stage products • Comparative Analysis IMT 504: Connectyx Technologies • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Inactive Products • Comparative Analysis Rabies infection Key Companies Rabies infection Key Products Rabies infection- Unmet Needs Rabies infection- Market Drivers and Barriers Rabies infection- Future Perspectives and Conclusion Rabies infection Analyst Views Rabies infection Key Companies Appendix

Table 1 Total Products for Rabies infection Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Synermore Biologics • Sanofi • Anhui Zhifei Longcom Biopharmaceutical • CureVac AG • Yisheng Biopharma • GlaxoSmithKline • Rabies G protein vaccine • Connectyx Technologies